Assembly Biosciences (ASMB) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Assembly Biosciences Advances ABI-1179 to Phase 1b in Clinical Study for Recurrent Genital Herpes With Promising Interim Results
Quiver QuantitativeFeb 20 08:13 ET
Express News | Assembly Biosciences: Phase 1B to Run Concurrently With Ongoing Phase 1B Study for Abi-5366, Interim Data for Both Candidates Expected in Fall 2025
ReutersFeb 20 08:05 ET
Express News | Assembly Biosciences Inc: Abi-1179 Was Well-Tolerated
ReutersFeb 20 08:00 ET
Express News | Assembly Biosciences Reports Positive Interim Phase 1a Results From Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Abi-1179 in Development for Recurrent Genital Herpes
ReutersFeb 20 08:00 ET
Assembly Biosciences Reports Positive Interim Phase 1a Results From Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor ABI-1179 in Development for Recurrent Genital Herpes
Assembly BiosciencesFeb 20 00:00 ET
Express News | Kacper Kłos Named CEO of Assembly Digital Commerce
ReutersJan 8 09:35 ET

Comments

Teddy123

Feb 20 07:21

Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor ABI-1179 in Development for Recurrent Genital Herpes

$Assembly Biosciences (ASMB.US)$
Can This New Once-Weekly Herpes Treatment Transform Patient Care? Phase 1a Results Reveal Breakthrough

Jaguar8

Feb 20 07:01

NEWS

$Assembly Biosciences (ASMB.US)$
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor ABI-1179 in Development for Recurrent Genital Herpes
Thursday, 20th February at 8:00 am
– ABI-1179 was well-tolerated, with a half-life of approximately four days and high exposure across the dose range evaluated supporting the potential for once-weekly oral administration at a low dose –
– Assembly Bio to move ABI-1179 directly ...

1

Jaguar8

Feb 10 18:48

🟤Watchlist, FEBRUARY 11,2025, Tuesday. NFA - DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, ...

77

10

5

Jaguar8

Feb 9 21:05

🟢Watchlist, FEBRUARY 10,2024, Monday. NFA -DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If...

62

17

5

Jaguar8

Feb 6 20:51

🟠Watchlist, FEBRUARY 7,2025, Friday. NFA- DrJag8 (I am not sure if I’ll be trading tomorrow)

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow...

59

8

4

ASMB Assembly Biosciences

Trade Overview

Capital Trend

News

Comments

Trending Stocks